First Graphene Ltd has extended its partnership with UK-based Vector Companies Group through a three-year Strategic Partner Agreement, coinciding with the launch of a graphene-enhanced heat flux sensor using First Graphene’s PureGRAPH material. The sensor, marketed under Vector’s Peltyr line, measures heat flow through building components to assess insulation performance, offering real-time data for energy efficiency improvements. This commercial application marks a significant step in moving graphene technology from development to industry use, with potential markets in construction, aerospace, and industrial monitoring. First Graphene will support Vector in the sensor’s rollout and explore further applications and customers under the new agreement.
First Graphene's recent partnership expansion and product launch provide context for readers. For those tracking Basic Materials, 12 of 38 US stocks rose while 26 fell on Pluang as of Sep 30, 2026 06:31 WIB. Notable movers include VALE at USD 13.35 with a 1-day change of -1.77% and a typical hold time of 108 days, WMS at USD 130.90 down 1.68%, and FCX at USD 70.88 down 1.47% with 96% buy order activity.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
